Transgender Women
13
2
2
8
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
15.4%
2 terminated out of 13 trials
80.0%
-6.5% vs benchmark
0%
0 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (13)
Progesterone in Gender Affirming Hormone Therapy Study
Comparing the Effects of Sublingual Estradiol Treatment Versus Oral Estradiol With Cyproterone Acetate (CPA) Treatment on The Coagulation System in Transgender Women: A Prospective, Controlled Cohort Study
Gender-affirming Voice Training With Visual Feedback
Effects of Gender-Affirming Hormone Therapy Among Transgender Women
Evaluating Drug Interactions Between Doravirine With Estradiol and Spironolactone in Healthy Transgender Women
To Reach Unrestricted Services for Transgender Women
Economic Navigation and Strengthening to Research Unrestricted Services for Transgender Women (ENTRUST)
Exploration of the Neo-Vagina Study
Long-acting Biomedical HIV Prevention in Transgender Women
Influences of Long Term Hormone Therapy on Physical Fitness and Vascular Function in Transgender Women
Same-Day PrEP Initiation and Sexual Health for Transgender Women
Voice Feminisation in Transgender Women
Peer-Delivered HIV Self-Testing, STI Self-Sampling and PrEP for Transgender Women in Uganda